Page last updated: 2024-08-17

aspartic acid and Autosomal Dominant Juvenile Parkinson Disease

aspartic acid has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (10.00)18.2507
2000's6 (60.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, D; Fu, W; Sun, X; Wang, X; Zheng, Z; Zhuang, W1
Bienaimée, MJ; Delmaire, C; Galanaud, D; Gaymard, B; Hartmann, A; Jodoin, N; Lannuzel, A; Lehéricy, S; Roze, E; Vidailhet, M1
Morin, P; Pereira, A; Tan, Y; Yu, F; Zhou, J1
Dunnett, SB; Fawcettt, JW; Schwiening, CJ; Sinclair, SR; Zietlow, R1
Hadjiconstantinou, M; Neff, NH; Podell, M; Smith, MA1
Benner, EJ; Boska, MD; Destache, CJ; Gendelman, HE; Lewis, TB; Mosley, RL; Nelson, JA; Uberti, M1
Ahmed, AE; Arabi, A; Brice, A; Dürr, A; Ibáñez, P; Lesage, S; Leutenegger, AL; Lohmann, E; Mukhtar, MM; Salih, MA1
Cantú-Martínez, L; Flores, Lde L; González, HC; Martínez, HR; Onofre-Castillo, J; Villarreal, HJ1
Blezer, EL; Jongsma, MJ; Olivier, B; Philippens, IH; van Vliet, SA; van Vlieta, SA; Vanwersch, RA1
de Mari, M; Federico, F; Ferrari, E; Lamberti, P; Lucivero, V; Mezzapesa, DM; Petruzzellis, M; Simone, IL1

Other Studies

10 other study(ies) available for aspartic acid and Autosomal Dominant Juvenile Parkinson Disease

ArticleYear
Neural metabolite changes in corpus striatum after rat multipotent mesenchymal stem cells transplanted in hemiparkinsonian rats by magnetic resonance spectroscopy.
    The International journal of neuroscience, 2013, Volume: 123, Issue:12

    Topics: Animals; Aspartic Acid; Cell Differentiation; Cell Survival; Choline; Corpus Striatum; Creatine; Disease Models, Animal; Female; Magnetic Resonance Spectroscopy; Male; Mesenchymal Stem Cell Transplantation; Microtubule-Associated Proteins; Neurons; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Time Factors; Tyrosine 3-Monooxygenase

2013
Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy.
    Brain : a journal of neurology, 2010, Volume: 133, Issue:Pt 8

    Topics: Aged; Aspartic Acid; Brain; Case-Control Studies; Cognition Disorders; Creatinine; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Diffusion Tensor Imaging; Female; Guadeloupe; Hallucinations; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Spectroscopy; Male; Parkinsonian Disorders; Supranuclear Palsy, Progressive

2010
Suppression of Nrdp1 toxicity by Parkin in Drosophila models.
    Biochemical and biophysical research communications, 2011, Dec-09, Volume: 416, Issue:1-2

    Topics: Amino Acid Substitution; Animals; Animals, Genetically Modified; Aspartic Acid; Cell Survival; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Drosophila melanogaster; Drosophila Proteins; Female; Humans; Male; Parkinsonian Disorders; Suppression, Genetic; Ubiquitin-Protein Ligases; Valine

2011
The release of excitatory amino acids, dopamine, and potassium following transplantation of embryonic mesencephalic dopaminergic grafts to the rat striatum, and their effects on dopaminergic neuronal survival in vitro.
    Cell transplantation, 2002, Volume: 11, Issue:7

    Topics: Animals; Aspartic Acid; Cell Death; Corpus Striatum; Dopamine; Excitatory Amino Acids; Extracellular Space; Female; Glutamic Acid; Graft Survival; Neurons; Parkinsonian Disorders; Potassium; Rats; Rats, Inbred Strains; Stem Cell Transplantation; Stem Cells; Substantia Nigra

2002
Proton magnetic resonance imaging and spectroscopy identify metabolic changes in the striatum in the MPTP feline model of parkinsonism.
    Experimental neurology, 2003, Volume: 179, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aspartic Acid; Brain; Cats; Choline; Corpus Striatum; Creatine; Disease Models, Animal; Disease Progression; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Neurologic Examination; Pargyline; Parkinsonian Disorders; Predictive Value of Tests; Protons; Tyrosine 3-Monooxygenase

2003
Quantitative 1H magnetic resonance spectroscopic imaging determines therapeutic immunization efficacy in an animal model of Parkinson's disease.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2005, Feb-16, Volume: 25, Issue:7

    Topics: Adoptive Transfer; Animals; Aspartic Acid; Cell Count; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Glatiramer Acetate; Immunization; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Mice; Microglia; MPTP Poisoning; Myelin Basic Protein; Nerve Degeneration; Nerve Tissue Proteins; Ovalbumin; Parkinsonian Disorders; Peptides; Substantia Nigra; T-Lymphocyte Subsets; Tyrosine 3-Monooxygenase

2005
Juvenile-onset Parkinsonism as a result of the first mutation in the adenosine triphosphate orientation domain of PINK1.
    Archives of neurology, 2006, Volume: 63, Issue:9

    Topics: Adenosine Triphosphate; Adolescent; Adult; Age of Onset; Alanine; Amino Acid Sequence; Aspartic Acid; DNA Mutational Analysis; Family Health; Female; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Mutation; Parkinsonian Disorders; Protein Kinases; Sudan

2006
Epilepsy, parkinsonism, and neuroleptic malignant syndrome in a child.
    Journal of child neurology, 2006, Volume: 21, Issue:12

    Topics: Anticonvulsants; Antiparkinson Agents; Aspartic Acid; Basal Ganglia; Benzothiazoles; Carbamazepine; Child; Electroencephalography; Epilepsy; Epilepsy, Complex Partial; Female; Humans; Magnetic Resonance Spectroscopy; Neuroleptic Malignant Syndrome; Parkinsonian Disorders; Phenytoin; Pramipexole; Time

2006
Exploring the neuroprotective effects of modafinil in a marmoset Parkinson model with immunohistochemistry, magnetic resonance imaging and spectroscopy.
    Brain research, 2008, Jan-16, Volume: 1189

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aspartic Acid; Benzhydryl Compounds; Biomarkers; Brain; Callithrix; Disease Models, Animal; Dopamine; Drug Administration Schedule; Immunohistochemistry; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Modafinil; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; Parkinsonian Disorders; Phosphocreatine; Predictive Value of Tests; Reproducibility of Results; Substantia Nigra; Treatment Outcome; Tyrosine 3-Monooxygenase

2008
Usefulness of proton magnetic resonance spectroscopy in differentiating parkinsonian syndromes.
    Italian journal of neurological sciences, 1999, Volume: 20, Issue:4

    Topics: Adult; Aged; Aspartic Acid; Brain; Choline; Creatine; Diagnosis, Differential; Disease Progression; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple System Atrophy; Parkinsonian Disorders; Phosphocreatine; Supranuclear Palsy, Progressive

1999